TORII PHARMACEUTICAL
Torii Pharmaceutical Co., Ltd. aims to contribute to the improvement of human health and to fulfill its responsibilities to customers, shareholders, society and employees, by supplying world-class pharmaceutical products.
TORII PHARMACEUTICAL
Industry:
Biotechnology Pharmaceutical
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Domain Not Resolving Apache
Similar Organizations
Kyowa Kirin
Kyowa Kirin is a pharmaceutical company contributing to human health and well-being of people around the world.
Otsuka Pharmaceutical
Otsuka Pharmaceutical is the provider of pharmaceutical and nutraceutical products.
Tasly Pharmaceutical
Tasly Pharmaceutical is a company that provides global market services with tech systems in the GMP.
Stock Details
More informations about "Torii Pharmaceutical"
Organization | Torii Pharmaceutical Co. Ltd.
The organization chart of Torii Pharmaceutical Co., Ltd. is shown.See details»
Torii Pharmaceutical - Crunchbase Company Profile
Torii Pharmaceutical aims to contribute to the improvement of human health and to fulfill its responsibilities to customers.See details»
Torii Pharmaceutical Co., Ltd. - Drug pipelines, Patents, Clinical ...
Explore Torii Pharmaceutical Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 39 clinical trials, 20 news, and 126 literature, Disease Domain:Immune System โฆSee details»
Torii Pharmaceutical Co Ltd - Company Profile - GlobalData
Torii Pharmaceutical Co Ltd (Torii), a subsidiary of Japan Tobacco Inc, is a pharmaceutical company. It develops and markets pharmaceutical products for chronic kidney disease (CKD), โฆSee details»
Torii Pharmaceutical (TYO:4551) Company Profile & Description
Company profile for Torii Pharmaceutical Co., Ltd. (TYO:4551) with a description, list of executives, contact details and other key facts.See details»
Notice of the Announcement by a Subsidiary Company
Today, TORII PHARMACEUTICAL CO., LTD. (Torii) (TSE:4551) has decided to implement the organizational reform as part of its business structural reform and a growth strategy set forth in โฆSee details»
Torii Pharmaceutical Co. Ltd.
This is the homepage of Torii Pharmaceutical Co., Ltd. We aim to contribute to the improvement of people's health by supplying world-class pharmaceutical products.See details»
Torii Pharmaceutical Co. Ltd - Disfold
Jan 1, 2025 Company Profile of Torii Pharmaceutical Co. Ltd with information on the company's activities, financials, digital presence, market capitalization, stocks and โฆSee details»
Torii Pharmaceutical - VentureRadar
"Torii Pharmaceutical engages in the manufacturing and marketing of pharmaceutical products. Its products are mainly used in the areas of renal diseases and hemodialysis, human โฆSee details»
Notice of Commencement of Tender Offer for Shares of TORII ...
May 7, 2025 Note 2: Source: โJapan Pharmaceutical Manufacturers Association Guide 2024โ by Japan Pharmaceutical Manufacturers Association. On the other hand, the Target Company โฆSee details»
Integrated Report | Torii Pharmaceutical Co. Ltd.
The annual reports of Torii Pharmaceutical Co., Ltd. are presented.See details»
Investor Relations | Torii Pharmaceutical Co. Ltd.
IR information is provided for the shareholders and investors. Torii Pharmaceutical Co., Ltd. aims to become a major player with distinguishing characteristics by improving the various โฆSee details»
For 2023 - torii.co.jp
Torii Pharmaceuticalโs Purpose are. We contribute to the healthy recovery of patients, as well as to a happy, enriched life free from fear of illSee details»
Corporate Profile | Torii Pharmaceutical Co. Ltd.
Dec 31, 2024 The corporate profile of Torii Pharmaceutical Co., Ltd. is shown.See details»
About Torii | Torii Pharmaceutical Co. Ltd.
The company information of Torii Pharmaceutical Co., Ltd. is provided. We aim to contribute to the improvement of human health and to fulfill its responsibilities to customers, shareholders, โฆSee details»
Drugmaker Shionogi to buy Japan Tobacco's unit Torii โฆ
May 7, 2025 Japanese drugmaker Shionogi said on Wednesday that it will acquire Torii Pharmaceutical , a subsidiary of Japan Tobacco , for more than 150 billion yen ($1.05 billion).See details»
Shionogi to Buy Torii in 160 Billion Yen Deal, JT Pulls Plug on โฆ
Oct 29, 2024 Shionogi said on May 7 that it is acquiring Torii Pharmaceutical, a subsidiary of Japan Tobacco (JT), as well as the pharmaceutical division of JT and US group company โฆSee details»
Shionogi pushes 2030 vision forward with $1 billion acquisition
May 8, 2025 Japanese drugmaker Shionogi (TYO: 4507) is to scale up its pipeline and global ambitions with a deal worth more than $1 billion, buying the pharmaceutical operations of โฆSee details»
Shionogi In $1bn Deal For Japan Tobaccoโs Pharma Ops
May 8, 2025 Shionogi is to pay around JPY151bn ($1.05bn) for Japan Tobaccoโs (JT) pharmaceutical operations, including listed subsidiary Torii Pharmaceutical, in what the mid โฆSee details»
Japan's Shionogi to acquire Torii Pharmaceutical from Japan โฆ
MLex Summary: Japanese pharmaceutical company Shionogi has agreed to acquire shares of Torii Pharmaceutical from Japan Tobacco, which holds a 54.8 percent stake in Torii, through a โฆSee details»